ABOUT

THE COMPANY

Improving global healthcare access thanks to a continuous and sustainable mRNA manufacturing solution.

Dillico was cofounded by senior industry experts for the purpose of developing and marketing a unique integrated and digitalized all-scale-range mRNA drug product manufacturing solution.

With its continuous and automated mRNA-LNP manufacturing system, Dillico is revolutionizing the landscape of the biopharma industry. Our proprietary flow technology and unique production process allow for the production of mRNA vaccines and therapies at any scale, from discovery to commercial manufacturing, using the same piece of equipment. This continuous all-scale solution significantly reduces the time and effort that goes into development, as well as offering unmatched flexibility in terms of production capacity.

TEAM

Meet the Senior Management Team

Christophe BonnevilleCEO & co-founder

Christophe Bonneville leads the company’s global strategy with a vision that champions the adoption of Pharma 4.0 solutions on the global pharma market. Previously, he was co-founder and CEO of Resolution Spectra, which was acquired by Merck Millipore in 2020 for its bioprocess monitoring solution. He has also held Business Unit Manager and Program Manager roles at various companies in the space industry. He holds a PhD in Physics, specifically in the field of Instrumental Optics, and is a graduate of Ecole Centrale de Marseille in France

Nicolas MoniotteCTO & co-founder

Nicolas Moniotte is a seasoned industry expert and consultant specializing in the technical development of vaccine products. He previously worked for GlaxoSmithKline and CureVac, where he was deeply involved in the development and transfer of mRNA-LNP manufacturing processes and analytical tools. Nicolas holds a PhD in Chemistry and a Masters in Applied Biology.

Flora BinderChief Development Officer & co-founder

Flora leads the process development of Dillico’s technology to provide robust, fully digitized and optimized manufacturing solutions. Previously, she has been working at Moderna and Biogen in Manufacturing Science, she was responsible of process technology transfer and validation activities. She received her Masters Degree in Biotechnology from Grenoble Alpes University.

PARTNERS

They trust us

CAREERS

Want to revolutionize the pharmaceutical industry?